Fitness expert Jillian Michaels has voiced criticism over Oprah Winfrey’s use of the weight-loss medication Ozempic.
In a statement to Page Six, Michaels expressed concerns about Winfrey’s financial ties to the drug. “Oprah is a significant shareholder in WeightWatchers, which has recently ventured into the Ozempic market,” Michaels remarked, suggesting a conflict of interest.
Michaels, known for her role on “The Biggest Loser,” emphasized the potential financial motivations behind promoting the drug, citing WeightWatchers’ acquisition of a company that facilitates access to weight-loss medications like Ozempic.
On the other hand, Oprah Winfrey shared her personal weight loss journey, highlighting her struggles with weight management over the years. The esteemed “Color Purple” actress discussed the relentless public scrutiny and personal guilt she faced, while also acknowledging the positive impact of her weight loss efforts.
Winfrey revealed her use of Ozempic as a part of her strategy to prevent weight fluctuations. She emphasized her commitment to a holistic approach, including regular exercise and mindful eating, in conjunction with the medication.
Determined to move past the stigma and self-judgment, the celebrated media figure declared an end to the shame associated with weight management, both from herself and others.
